Abstract:In recent years, multidrug-resistant pathogenic microorganisms (MDROs) have emerged as a severe threat to human health, exhibiting robust resistance to traditional antibiotics. This has created a formidable challenge in modern medicine as we grapple with limited options to combat these resilient bacteria. Despite extensive efforts by scientists to develop new antibiotics targeting these pathogens, the quest for novel antibacterial molecules has become increasingly arduous. Fortunately, nature offers a potential solution in the form of cationic antimicrobial peptides (AMPs) and their synthetic counterparts. AMPs, naturally occurring peptides, have displayed promising efficacy in fighting bacterial infections by disrupting bacterial cell membranes, hindering their survival and reproduction. These peptides, along with their synthetic mimics, present an exciting alternative in combating antibiotic resistance. They hold the potential to emerge as a formidable tool against MDROs, offering hope for improved strategies to protect communities. Extensive research has explored the diversity, history, and structure-properties relationship of AMPs, investigating their amphiphilic nature for membrane disruption and mechanisms of action. However, despite their therapeutic promise, AMPs face several documented limitations. Among these challenges, poor pharmacokinetic properties stand out, impeding the attainment of therapeutic levels in the body. Additionally, some AMPs exhibit toxicity and susceptibility to protease cleavage, leading to a short half-life and reduced efficacy in animal models. These limitations pose obstacles in developing effective treatments based on AMPs. Furthermore, the high manufacturing costs associated with AMPs could significantly hinder their widespread use. In this review, we aim to present experimental and theoretical insights into different AMPs, focusing specifically on antibacterial peptides (ABPs). Our goal is to offer a concise overview of peptide-based drug candidates, drawing from a wide array of literature and peer-reviewed studies. We also explore recent advancements in AMP development and discuss the challenges researchers face in moving these molecules towards clinical trials. Our main objective is to offer a comprehensive overview of current AMP and ABP research to guide the development of more precise and effective therapies for bacterial infections.

Wasp Venom: Future Breakthrough in Production of Antimicrobial Peptides

Wasp Venom Biochemical Components and Their Potential in Biological Applications and Nanotechnological Interventions

Venom: A Promising Avenue for Antimicrobial Therapeutics

Venomics AI: a computational exploration of global venoms for antibiotic discovery

Structure-function-guided design of synthetic peptides with anti-infective activity derived from wasp venom

Antimicrobial Potential of Scorpion-Venom-Derived Peptides

Beyond the venom: Exploring the antimicrobial peptides from Androctonus species of scorpion

New bioactive peptides from the venom gland of a social hornet Vespa velutina

Antimicrobial Peptides: Recent Insights on Biotechnological Interventions and Future Perspectives

Therapeutic Prospection of Animal Venoms-Derived Antimicrobial Peptides against Infections by Multidrug-Resistant Acinetobacter baumannii: A Systematic Review of Pre-Clinical Studies

Antimicrobial Peptides: The Production of Novel Peptide-Based Therapeutics in Plant Systems

A New Era of Antibiotics: The Clinical Potential of Antimicrobial Peptides

Antimicrobial Peptides: A Promising Therapeutic Strategy in Tackling Antimicrobial Resistance

Antimicrobial Peptides and Proteins: From Nature’s Reservoir to the Laboratory and Beyond

Advancements in peptide-based antimicrobials: A possible option for emerging drug-resistant infections

Evaluation of the bioactivity of a mastoparan peptide from wasp venom and of its analogues designed through targeted engineering

Antimicrobial Peptides as Effective Agents Against Drug-Resistant Pathogens

Biochemistry, Mechanistic Intricacies, and Therapeutic Potential of Antimicrobial Peptides: An Alternative to Traditional Antibiotics

A Critical Review of Short Antimicrobial Peptides from Scorpion Venoms, Their Physicochemical Attributes, and Potential for the Development of New Drugs

Recent advances in antimicrobial peptide-based therapy

LC-AMP-I1, a novel venom-derived antimicrobial peptide from the wolf spider Lycosa coelestis